title: Effects of FGF-1 and FGF-2 on GD3 immunoreactive spinal neuroepithelial cells.
abstract: Embryonic central nervous system neuroepithelial cells are a transient population of cells that give rise to neuronal and glial progenitors. In the E12-E16 embryonic rat spinal neural tube we have identified neuroepithelial cells as radially oriented cells expressing the GD3 ganglioside as recognized by the monoclonal anti-GD3 ganglioside antibodies, R24 and LB1. In vitro, neuroepithelial cells, which migrate from the ventral aspect of E12 rat lumbosacral neural tube explants, also express GD3 ganglioside immunoreactivity, thus permitting their distinction from neural crest cells (NCC) which migrate from the dorsal aspect of such explants. Fibroblast growth factor-1 (FGF-1, acidic FGF) and FGF-2 (basic FGF) increase the migration of neuroepithelial cells and the extent to which they incorporate the thymidine analogue bromodeoxyuridine (BrdU). They do not, however, alter the rate at which these migrating neuroepithelial cells undergo cell death. Previous observations established the actions of FGF-1 and FGF-2 on neuronal and glial cells. The present study indicates that these growth factors also influence the motility and proliferation of progenitor cells at a developmental stage which precedes their divergence into neuronal and glial lineages.
authors.affiliation: Abramson Pediatric Research Center, Children's Hospital of Philadelphia, PA 19104, USA.
authors.forename: P G
authors.initials: PG
authors.lastname: Bannerman
authors.forename: T M
authors.initials: TM
authors.lastname: Oliver
authors.forename: Z
authors.initials: Z
authors.lastname: Xu
authors.forename: A
authors.initials: A
authors.lastname: Shieh
authors.forename: D E
authors.initials: DE
authors.lastname: Pleasure
mesh_terms: D000818:Animals; D000963:Antimetabolites; D001973:Bromodeoxyuridine; D016923:Cell Death / Q000187:drug effects; D002455:Cell Division / Q000187:drug effects / Q000502:physiology; D002465:Cell Movement; D004247:DNA / Q000096:biosynthesis; D004847:Epithelial Cells; D004848:Epithelium / Q000187:drug effects / Q000378:metabolism; D016220:Fibroblast Growth Factor 1 / Q000494:pharmacology*; D051526:Fibroblast Growth Factor 10; D016222:Fibroblast Growth Factor 2 / Q000494:pharmacology*; D051523:Fibroblast Growth Factor 7; D005346:Fibroblast Growth Factors; D019084:Fluorescent Antibody Technique, Indirect; D005732:Gangliosides / Q000378:metabolism*; D006133:Growth Substances / Q000494:pharmacology; D007150:Immunohistochemistry; D007700:Kinetics; D009432:Neural Crest / Q000166:cytology / Q000187:drug effects; D051381:Rats; D017207:Rats, Sprague-Dawley; D013116:Spinal Cord / Q000166:cytology / Q000187:drug effects / Q000378:metabolism*
chemical_list: D000963:Antimetabolites; C496455:Fgf7 protein, rat; D051526:Fibroblast Growth Factor 10; D005732:Gangliosides; D006133:Growth Substances; D016222:Fibroblast Growth Factor 2; D016220:Fibroblast Growth Factor 1; D051523:Fibroblast Growth Factor 7; C026226:ganglioside, GD3; D005346:Fibroblast Growth Factors; D004247:DNA; D001973:Bromodeoxyuridine